A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.
Despite decades of research into risk-reduction strategies, cardiovascular disease and renal disease remain leading causes of morbidity and mortality among patients with type 2 diabetes mellitus. Given the tight clustering of cardiovascular and renal disease with the metabolic abnormalities of type 2 diabetes mellitus, we can think of these conditions together as cardiovascular-renal-metabolic disease states. A holistic view of cardiovascular-renal-metabolic disease states is critical to provide integrated patient-centered care to individuals with these disease states. Here, we explore the cardiovascular and renal risks associated with type 2 diabetes mellitus and highlight the importance of reducing cardiovascular-renal-metabolic disease risk in a comprehensive manner. We advocate a cross-disciplinary, team-based model to manage cardiovascular-renal-metabolic disease risk among patients with type 2 diabetes mellitus.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Risk Assessment
- Patient-Centered Care
- Models, Organizational
- Humans
- General & Internal Medicine
- Diabetic Nephropathies
- Diabetic Cardiomyopathies
- Diabetic Angiopathies
- Diabetes Mellitus, Type 2
- Cardiometabolic Risk Factors
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Risk Assessment
- Patient-Centered Care
- Models, Organizational
- Humans
- General & Internal Medicine
- Diabetic Nephropathies
- Diabetic Cardiomyopathies
- Diabetic Angiopathies
- Diabetes Mellitus, Type 2
- Cardiometabolic Risk Factors